ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date

Monday, November 14, 2016

9:00AM-11:00AM
Abstract Number: 1895
Increased CXCL4/PF4 Presence in Systemic Sclerosis and Absence of Heparin Directed Autoantibodies
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II
9:00AM-11:00AM
Abstract Number: 1077
Increased Expression of B-Cell Lipid Rafts in Patients with Primary Sjogren’s Syndrome Correlated Positively with Disease Activity Score, Suggesting a B Cell Activated State Potentially Relevant for the Disease Pathogenesis and Response to Biologic Therapies
B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's
9:00AM-11:00AM
Abstract Number: 1509
Increased Fracture Risk in Patients with Early Rheumatoid Arthritis in the 1990s As Well As in the 2000s: A Prospective General Population-Matched Cohort Study
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications
9:00AM-11:00AM
Abstract Number: 1787
Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life
9:00AM-11:00AM
Abstract Number: 1832
Increased Interferon b Expression in Bone Marrow Mediates a Senescent Phenotype and Impaired Production of Immunomodulatory Factors By SLE Mesenchymal Stromal Cells
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I
9:00AM-11:00AM
Abstract Number: 1474
Increased Levels of Lipoprotein(a) in RA Patients with Cardiovascular Disease
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications
9:00AM-11:00AM
Abstract Number: 1468
Increased Mitral and Tricuspid Valve Regurgitation Among Mexican Mestizo Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications
9:00AM-11:00AM
Abstract Number: 1894
Increased Mortality in Systemic Sclerosis Patients with Fibrosing Myopathy
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II
9:00AM-11:00AM
Abstract Number: 1854
Increased Percentage of CD204/CD206 Double Positive Monocytes Correlates with Specific Lung and Skin Involvement Parameters and an “Active” Capillaroscopic Pattern of Microangiopathy in Systemic Sclerosis Patients
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II
9:00AM-11:00AM
Abstract Number: 1118
Increased Population of Myeloid Dendritic Cells and Upregulated Gene Expression of Tnfα Is Associated with Poor Response to Hydroxychloroquine
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster I
9:00AM-11:00AM
Abstract Number: 1185
Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan
Epidemiology and Public Health - Poster II
9:00AM-11:00AM
Abstract Number: 1528
Incretin Axis in Non Diabetic Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications
9:00AM-11:00AM
Abstract Number: 1926
Indications for Testing and Diagnostic Outcome in Patients with Positive ANCA at a Canadian Tertiary Care Centre
Vasculitis - Poster II: ANCA-Associated Vasculitis
9:00AM-11:00AM
Abstract Number: 1328
Infective Endocarditis with Septic Arthritis: A Single-Center Experience
Infection-related Rheumatic Disease - Poster
9:00AM-11:00AM
Abstract Number: 1286
Inflammatory Activity of IgG4-Related Disease Lesions Assessed By Quantitative Positron Emission Tomography Correlates with Circulating Plasmablasts Levels
Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI
  • «Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 68
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology